Sinopharm Group Co. Ltd. (HKG:1099)

Market Cap	52.80B -8.0%
Revenue (ttm)	652.76B -0.8%
Net Income	8.08B +0.4%
EPS	2.58 -0.0%
Shares Out	3.12B
PE Ratio	6.56
Forward PE	5.79
Dividend	0.80 (4.72%)
Ex-Dividend Date	Jun 23, 2026

Volume	7,171,382
Open	16.92
Previous Close	16.92
Day's Range	16.78 - 17.10
52-Week Range	16.81 - 22.34
Beta	0.48
Analysts	Buy
Price Target	23.13 (+36.06%)
Earnings Date	Aug 28, 2026

About Sinopharm Group

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 94,910
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1099

Financial Performance

In 2025, Sinopharm Group's revenue was 575.17 billion, a decrease of -1.60% compared to the previous year's 584.51 billion. Earnings were 7.16 billion, an increase of 1.50%.

Financial numbers in CNY